Bristol-Myers Squibb and Tsinghua University Announce Collaboration to Accelerate Early Research into Potential Therapies for Autoimmune Diseases and Cancer

Life Science

WebMD and Tencent Partner to Deliver Health Information in China

Life Science

CICC’s Subsidiary Leads $103M Series B In Tumor Radiotherapy Start-up Allcure Medical

Life Science

Luye Pharma Well Positioned for CNS Market with the Approval of A New Indication for Seroquel XR in China

Life Science

BeiGene Shows Off Strong Results from Checkpoint Inhibitor While Eying Potential Approval for BTK Inhibitor

Life Science

Long Hill Capital Closes $265 Million Second Fund for China Health Investments

Life Science

Agios Pharmaceuticals Scores FDA Approval For Tibsovo, Second AML Drug Win in Less Than a Year

Life Science

Kolon Life Science to Export $207 Million of Gene Therapy Treatment to China’s Hainan Province

Life Science

Shanghai Fosun Pharma Considering $500 Million IPO of Gland Pharma

Life Science

Quantapore Inc. Closes Series 3 Financing Round to Fund Beta Launch of DNA Sequencer

Life Science

Alpine Immune Sciences Completes Sale of S-Nitrosoglutathione Reductase (GSNOR) Assets to Laurel Venture Capital

Life Science

Shanghai Pharmas Form Union to Fix Short Supply of Drugs for Rare Diseases

Life Science

Canadian marijuana company Tilray has first US pot IPO

Cannabis, Life Science

Takeda Eyes China Drug Market as its Next Big Opportunity Following Shire Deal

Life Science

Shuwen Biotech’s Clinical Lab Successfully Passes Biyearly College of American Pathologists Audit

Life Science